Results for tag: "Rebamipide"

Rebamipide is a gastrointestinal drug used to treat gastric and duodenal ulcers, gastritis, and reflux esophagitis. It is a proton pump inhibitor that works by reducing the amount of acid produced in the stomach. It is also used to treat symptoms of gastroesophageal reflux disease (GERD) such as heartburn and acid regurgitation. Rebamipide is available in tablet, capsule, and suspension forms. It is usually taken twice daily with or without food. Rebamipide is a relatively new drug and is not widely available in many countries. It is approved for use in Japan, South Korea, and Taiwan. In Japan, it is the most commonly prescribed proton pump inhibitor. The Rebamipide market is highly competitive, with several companies offering their own versions of the drug. Some of the major players in the market include Takeda Pharmaceuticals, Daiichi Sankyo, Astellas Pharma, and Otsuka Pharmaceuticals. Other companies such as Shionogi & Co., Ltd., and Mitsubishi Tanabe Pharma Corporation also offer Rebamipide products. Show Less Read more